Allergan tries to escape Restasis IPRs
bee32 / iStockphoto.com
A Native American tribe that has signed a patent deal with Allergan has requested information on the Patent Trial and Appeal Board (PTAB) judges overseeing inter partes reviews (IPRs) involving the tribe.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at firstname.lastname@example.org
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
generics, Restasis, patent invalidation, Allergan, Saint Regis Mohawk Tribe, PTAB, IPR, sovereign immunity